Bayer has agreed with plaintiffs’ counsel on a plan the company said is “designed to manage and resolve future Roundup cases,” a key component of settling thousands of claims against the company over exposure to the widely used herbicide.
Bayer and attorneys for a proposed class of potential future Roundup plaintiffs will go back to the drawing board after a federal judge expressed skepticism over the legality and fairness of their proposed settlement.
Bayer has announced “a series of agreements that will substantially resolve major outstanding Monsanto litigation,” including payments of up to $10.9 billion to settle current and future Roundup claims against the company and $400 million to settle dicamba drift damage complaints.
Lawyers for Monsanto and Dewayne Lee Johnson squared off Tuesday before a California appeals court over whether he should be compensated for exposure to Roundup that he claims caused his non-Hodgkin lymphoma.
A trial in St. Louis involving a plaintiff who alleges exposure to Roundup caused her non-Hodgkin lymphoma has been delayed indefinitely, leading to speculation that Bayer and plaintiffs’ lawyers need the time to work out a settlement.
A California state court judge has significantly reduced damages awarded to a couple whose non-Hodgkin lymphoma was blamed on Roundup exposure, cutting their overall award from more than $2 billion to $86.7 million.
A California jury has awarded a married couple who developed non-Hodgkin’s lymphoma more than $2 billion in punitive and other damages after concluding Monsanto failed to warn them about the risks of spraying Roundup.
The Environmental Protection Agency has reaffirmed its conclusion that glyphosate, the active ingredient in Bayer’s Roundup, is probably not carcinogenic, in a proposed registration decision that would allow the herbicide to continue to be used in the United States.